These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 14082331)

  • 1. [EXPERIMENTAL STUDIES ON THE EFFECT OF CIGARETTE SMOKING ON THE COAGULATION TIME OF NORMAL BLOOD AND CALCIUM-TREATED BLOOD AND ON THE PROTHROMBIN AND THROMBIN TIME OF HUMAN SERUM].
    LISIEWICZ J
    Pol Tyg Lek; 1963 Sep; 18():1471-3. PubMed ID: 14082331
    [No Abstract]   [Full Text] [Related]  

  • 2. [A SIMPLE MODIFICATION OF THE 1-STEP PROCEDURE FOR DETERMINATION OF THROMBIN TIME, QUANTITY OF FIBRINOGEN AND FIBRINOLYTIC ACTIVITY OF THE BLOOD].
    KUZNIK BI
    Vopr Med Khim; 1964; 10():316-8. PubMed ID: 14221560
    [No Abstract]   [Full Text] [Related]  

  • 3. [PRELIMINARY STUDIES OF THE BLOOD COAGULATION SYSTEM IN UREMIA].
    JUSKOWA J
    Pol Arch Med Wewn; 1964; 34():1183-9. PubMed ID: 14235107
    [No Abstract]   [Full Text] [Related]  

  • 4. ROLE OF THROMBIN IN PROTHROMBIN ACTIVATION.
    SEEGERS WH; SCHROEER H; HEENE D
    Thromb Diath Haemorrh; 1964 Dec; 12():484-8. PubMed ID: 14254705
    [No Abstract]   [Full Text] [Related]  

  • 5. A simple means to determine exact moment of clotting in prothrombin or thrombin time determination.
    HONORATO R
    Proc Soc Exp Biol Med; 1947 May; 65(1):41. PubMed ID: 20243114
    [No Abstract]   [Full Text] [Related]  

  • 6. [DISTURBANCES IN THE CHAIN-REACTION OF THROMBIN FORMATION CAUSING HEMORRHAGIC DIATHESIS].
    KOWARZYK H
    Z Gesamte Inn Med; 1965 Feb; 20():SUPPL:273 F. PubMed ID: 14264681
    [No Abstract]   [Full Text] [Related]  

  • 7. BLOOD COAGULATION--A BASIC SCIENCE REVIEW.
    MILSTONE JH
    Conn Med; 1964 Sep; 28():653-6. PubMed ID: 14201316
    [No Abstract]   [Full Text] [Related]  

  • 8. [DISTURBANCES IN THE CHAIN-REACTION OF THROMBIN FORMATION AS A CAUSE OF HEMORRHAGIC DIATHESIS].
    KOWARZYK H
    Z Gesamte Inn Med; 1965 Feb; 20():SUPPL:269-72 C. PubMed ID: 14270015
    [No Abstract]   [Full Text] [Related]  

  • 9. STUDY OF THE ANTI-THROMBOTIC PROPERTIES OF DEXTRANS OF LARGE MOLECULAR WEIGHT.
    BRYANT MF; BLOOM WL; BREWER SS
    J Cardiovasc Surg (Torino); 1964; 5():48-52. PubMed ID: 14109832
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON SOME INDICES OF THE BLOOD COAGULATION AND ANTICOAGULATION SYSTEM IN PATIENTS WITH MYOCARDIAL INFARCT AND CORONARY INSUFFICIENCY].
    KONIAEV BV; RUBNEVA PA; VIUSHINA OP; NEKLIUDOVA VI; SYCHEVA IK
    Kardiologiia; 1964; 4():16-22. PubMed ID: 14152583
    [No Abstract]   [Full Text] [Related]  

  • 11. SEDIMENTATION ANALYSES AND EXCLUSION CHROMATOGRAPHY OF PREPARATIONS OF HUMAN PROTHROMBIN AND THROMBIN.
    LANCHANTIN GF; FRIEDMANN JA
    Vox Sang; 1964; 9():228-31. PubMed ID: 14147445
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of the relationship of concentrations of prothrombin, proconvertin, and proaccelerin to three methods for measuring prothrombin time.
    GONYEA LM; HJORT P; OWREN PA
    J Lab Clin Med; 1956 Oct; 48(4):624-33. PubMed ID: 13367602
    [No Abstract]   [Full Text] [Related]  

  • 13. The antithrombic activity of carrageenin in human blood.
    HAWKINS WW; LEONARD VG
    Can J Biochem Physiol; 1963 May; 41():1325-7. PubMed ID: 13953223
    [No Abstract]   [Full Text] [Related]  

  • 14. INCREASED SENSITIVITY TO HEPARIN FOLLOWING ACUTE MYOCARDIAL INFARCTION.
    DUFAULT C
    Can Med Assoc J; 1965 Jan; 92(1):13-5. PubMed ID: 14216140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of prothrombin determination and thrombin degradation time in various surgical diseases and their variations under the influence of surgery].
    FONTAINE R; MANDEL P; AMIOT A; RIVEAUX R
    Lyon Chir; 1951; 46(2):169-84. PubMed ID: 14814916
    [No Abstract]   [Full Text] [Related]  

  • 16. [EVALUATION OF METHODS FOR THE DETERMINATION OF THE PROTHROMBIN COMPLEX ACTIVITY].
    MARES J; PODLIPNY J
    Z Arztl Fortbild (Jena); 1964 Jun; 58():709-13. PubMed ID: 14240434
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 18. The blood coagulation mechanism with especial reference to the prothrombin-proconvertin contents of plasma during long-term ACTH or cortisone therapy.
    FISCHER F; LUND E
    Acta Med Scand; 1954; 149(3):179-85. PubMed ID: 13180225
    [No Abstract]   [Full Text] [Related]  

  • 19. Prothrombin and proconvertin in the newborn and during the first year of life.
    DYGGVE H
    Acta Paediatr (Stockh); 1958 May; 47(3):251-9. PubMed ID: 13532682
    [No Abstract]   [Full Text] [Related]  

  • 20. COAGULATION STUDIES IN EXTRACORPOREAL CIRCULATION.
    DYBKJAER E; BERG E; KISSMEYER-NIELSEN F
    Acta Chir Scand; 1964 Oct; 128():350-61. PubMed ID: 14211290
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.